Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone

Article metrics

  • A Correction to this article was published on 03 August 1995

Abstract

KAPOSI'S sarcoma (KS) occurs more often in men than in women and HIV-l-associated KS has a high occurrence in homosexual men (over 30%). Most cultures of KS tumours yield cells with properties of hyperplastic (not malignant) endothelial cells under the control of several cytokines1á€-7. The role of HIV-1 may be in promoting high levels of some cytokines and providing stimulation to angiogenesis by the HIV-1 Tat protein8, which synergizes with basic fibroblast growth factor in promoting these effects9. Here we describe an immortalized AIDS-KS cell line (KS Y-l) and show that these cells produce malignant metastatic tumours in nude mice and are killed in vitro and in vivo (apparently by apoptosis) by a pregnancy hormone, the β-chain of human chorionic gonadotropin. Similarly, chorionic gonadotropin kills KS SLK, cells from another neoplastic cell line (established from a non-HIV-associated KS)10, as well as the hyper plastic KS cells from clinical specimens grown in short-term culture, but does not kill normal endothelial cells. These results provide evidence that KS can evolve into a malignancy and have implications for the hormonal treatment of this tumour.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Nakamura, S. et al. Science 242, 426–430 (1988).

  2. 2

    Ensoli, B. et al. Science 243, 223–226 (1989).

  3. 3

    Salahuddin, S. Z. et al. Science 242, 430–433 (1988).

  4. 4

    Miles, S. et al. Science 255, 1432–1434 (1992).

  5. 5

    Sturzl, M. et al. Proc. natn. Acad. Sci. U.S.A. 89, 7046–7050 (1992).

  6. 6

    Masood, R. et al. AIDS Res. Hum. Retroviruses 10, 969–975 (1994).

  7. 7

    Cai, J. et al. Am. J. Path. 145, 74–79 (1994).

  8. 8

    Ensoli, B. et al. Nature 344, 84–86 (1990).

  9. 9

    Ensoli, B. et al. Nature 371, 674–680 (1994).

  10. 10

    Siegal, B. et al. Cancer 65, 492–498 (1990).

  11. 11

    Lunardi-Iskandar, Y. et al. J. exp. Med. 177, 741–750 (1993).

  12. 12

    Markham, P. et al. Int. J. Cancer 31, 413–420 (1983).

  13. 13

    Cohen, J. J. Adv. Immun. 50, 55–85 (1991).

  14. 14

    Clarke, P. G. H. et al. Anat. Embryol. 181, 195–213 (1990).

  15. 15

    Kornyei, J. L., Lei, Z. M. & Rao, C. V. Biol. Reprod. 49, 1149–1157 (1993).

  16. 16

    Torry, R. & Rongish, B. J. Am. J. reprod. Immun. 27, 171–179 (1992).

  17. 17

    Fan, C. et al. J. clin. Endocrin. Metab. 64, 313–318 (1987).

  18. 18

    Ashitaka, Y. et al. in Chorionic Gonadotrophin (ed. Segal, S. J.) 147–175 (Plenum, New York, 1980).

  19. 19

    Stimson, W. H. in Immunology of Reproduction (ed. Wegman, T. G.) 281–301 (Oxford Univ. Press, New York, 1983).

  20. 20

    Home, C. H. W. & Nisbet, A. D. Invest. Cell Path. 2, 217–219 (1979).

  21. 21

    Elmazar, M. M. et al. Reprod. Toxicol. 3, 135–138 (1989).

  22. 22

    Pierce, J. G. & Parsons, T. F. A. Rev. Biochem. 50, 465–495 (1981).

  23. 23

    Martin, M. C. et al. in Basic and Clinioal Endocrinology, The Endocrinology of Pregnancy (ed. Greenspan, F. S.) 543–568 (Appleton & Lange, Connecticut, 1991).

  24. 24

    Wide, L. et al. in Chorionic Gonadotrophin (ed. Segal, S. J.) 37–51 (Plenum, New York, 1980).

  25. 25

    Johnson, M. R. et al. Acta Endocrin. 29, 121–125 (1993).

  26. 26

    Sahraoui, Y. et al. Cell. Immun. 139, 318–332 (1992).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lunardi-lskandar, Y., Bryant, J., Zeman, R. et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375, 64–68 (1995) doi:10.1038/375064a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.